Bharat Biotech Seeks Permission To Conduct Phase-3 Study Of Intranasal Covid Vaccine In The 5-18 Age Group
DCGI had approved Bharat Biotech's intranasal Covid vaccine for restricted emergency use in those aged above 18 years.
iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with pre-fusion stabilised spike protein.
The vaccine was evaluated in phase 2 and 3 clinical trials with successful results.
Source: PTI
India witnessed its fresh Covid-19 tally fall further. Recoveries outpaced new cases. About 5,076 new cases were reported in the last 24 hours. There were 5,970 recoveries and 11 deaths.
The country covid-19 vaccination coverage has exceeded 214.95 crore, as per provisional reports till 7 AM on Sunday
CORONAVIRUS INDIA UPDATE
India reports 5,076 new Covid-19 cases, 5,970 recoveries and 11 deaths in the last 24 hours.
Total confirmed cases: 4,44,95,359
Total number of active cases: 47,945
Total patients cured/discharged/migrated: 4,39,19,264
Total deaths: 5,28,150
Number of fresh cases in last 24 hours: 5,076
One-day recoveries: 5,970
One-day deaths: 11
Source: Health Ministry (September 11)
RECOMMENDED FOR YOU
POPULAR